Liver Diseases  >>  mipsagargin (G-202)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mipsagargin (G-202) / Rebus
NCT01777594: Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma

Completed
2
25
US
G-202, Mipsagargin
GenSpera, Inc.
Advanced Adult Hepatocellular Carcinoma
03/15
03/15

Download Options